Febuxostat and renal outcomes: post-hoc analysis of a randomized trial-Reference-Cited by-同舟云学术

Febuxostat and renal outcomes: post-hoc analysis of a randomized trial

Published:2023-02-07 Issue:6 Volume:46 Page:1417-1422
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Kohagura Kentaro,Kojima Sunao,Uchiyama Kazuaki,Yokota Naoto,Tokutake Eiichi,Wakasa Yutaka,Hiramitsu Shinya,Waki Masako,Jinnouchi Hideaki,Kakuda Hirokazu,Hayashi Takahiro,Kawai Naoki,Sugawara Masahiro,Mori Hisao,Tsujita Kenichi,Matsui Kunihiko,Hisatome Ichiro,Ohya Yusuke,Kimura Kazuo,Saito Yoshihiko,Ogawa Hisao,

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

https://www.nature.com/articles/s41440-023-01198-x.pdf

Reference16 articles.

1. Nishizawa H, Maeda N, Shimomura I. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease. Hypertens Res. 2022;45:635–40. https://doi.org/10.1038/s41440-021-00840-w

2. Chen Q, Wang Z, Zhou J, Chen Z, Li Y, Li S, et al. Effect of urate-lowering therapy on cardiovascular and kidney outcomes: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2020;15:1576–86. https://doi.org/10.2215/CJN.05190420

3. Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, et al. Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med. 2020;382:2504–13. https://doi.org/10.1056/NEJMoa1915833

4. Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, et al. Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med. 2020;382:2493–503. https://doi.org/10.1056/NEJMoa1916624

5. Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, et al. Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis. 2018;72:798–810. https://doi.org/10.1053/j.ajkd.2018.06.028

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in pharmacotherapies for hyperuricemia;Expert Opinion on Pharmacotherapy;2023-03-30

2. Effects of Uric Acid-Lowering Therapy on the Kidney (HTR-2023-0096.R2);Hypertension Research;2023-03-08